Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PGE2 | cPLA2i | 1.0 | BCD110605C16 | 0.247 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 1.0 | BCD110605C18 | 0.144 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 1.0 | BCD110605C17 | 0.129 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 4.0 | BCD110605C34 | 0.137 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 4.0 | BCD110605C36 | 0.194 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 4.0 | BCD110605C35 | 0.227 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 20.0 | BCD110605C53 | 0.152 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 20.0 | BCD110605C54 | 0.329 | pmol/ml of medium |
| - | PGE2 | cPLA2i | 20.0 | BCD110605C52 | 0.326 | pmol/ml of medium |
| - | PGE2 | PLDi | 1.0 | BCD110605C10 | 0.163 | pmol/ml of medium |
| - | PGE2 | PLDi | 1.0 | BCD110605C12 | 0.155 | pmol/ml of medium |
| - | PGE2 | PLDi | 1.0 | BCD110605C11 | 0.195 | pmol/ml of medium |
| - | PGE2 | PLDi | 4.0 | BCD110605C30 | 0.067 | pmol/ml of medium |
| - | PGE2 | PLDi | 4.0 | BCD110605C29 | 0.127 | pmol/ml of medium |
| - | PGE2 | PLDi | 4.0 | BCD110605C28 | 0.163 | pmol/ml of medium |
| - | PGE2 | PLDi | 20.0 | BCD110605C48 | 0.283 | pmol/ml of medium |
| - | PGE2 | PLDi | 20.0 | BCD110605C47 | 0.228 | pmol/ml of medium |
| - | PGE2 | PLDi | 20.0 | BCD110605C46 | 0.292 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 1.0 | BCD110605C19 | 0.303 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 1.0 | BCD110605C21 | 0.269 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 1.0 | BCD110605C20 | 0.328 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 4.0 | BCD110605C39 | 0.573 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 4.0 | BCD110605C37 | 0.409 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 4.0 | BCD110605C38 | 0.502 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 20.0 | BCD110605C55 | 1.49 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 20.0 | BCD110605C57 | 2.59 | pmol/ml of medium |
| - | PGE2 | KDO+cPLA2i | 20.0 | BCD110605C56 | 2.47 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 1.0 | BCD110605C15 | - | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 1.0 | BCD110605C14 | 0.728 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 1.0 | BCD110605C13 | 0.341 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 4.0 | BCD110605C32 | 1.64 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 4.0 | BCD110605C31 | 2.11 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 4.0 | BCD110605C33 | 1.74 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 20.0 | BCD110605C49 | 8.86 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 20.0 | BCD110605C51 | 8.93 | pmol/ml of medium |
| - | PGE2 | KDO+PLDi | 20.0 | BCD110605C50 | 9.33 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 1.0 | BCD110605C07 | 0.657 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 1.0 | BCD110605C09 | 0.528 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 1.0 | BCD110605C08 | 1.01 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 4.0 | BCD110605C25 | 2.05 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 4.0 | BCD110605C26 | 1.94 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 4.0 | BCD110605C27 | 1.95 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 20.0 | BCD110605C45 | 8.25 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 20.0 | BCD110605C43 | 7.51 | pmol/ml of medium |
| - | PGE2 | KDO + ATP | 20.0 | BCD110605C44 | 8.44 | pmol/ml of medium |
| - | PGE2 | C | 0.0 | BCD110605C02 | 0.139 | pmol/ml of medium |
| - | PGE2 | C | 0.0 | BCD110605C01 | 0.128 | pmol/ml of medium |
| - | PGE2 | C | 0.0 | BCD110605C03 | 0.171 | pmol/ml of medium |
| - | PGE2 | C | 1.0 | BCD110605C06 | 0.091 | pmol/ml of medium |
| - | PGE2 | C | 1.0 | BCD110605C05 | 0.107 | pmol/ml of medium |